Latest Healthcare News

Page 14 of 197
ECS Botanics is taking six Australian-grown medicinal cannabis flower products into the UK through Curaleaf Laboratories, with initial supply targeted for November. The two-year deal offers access to UK sell-through but no guaranteed volumes, revenue or minimum purchases.
Victor Sage
Victor Sage
7 Oct 2026
An independent, Rhythm-funded economic model estimates its ColoSTAT blood test could avoid 29,427 public-hospital colonoscopies a year and deliver $72.4 million in net annual hospital savings. The figures strengthen Rhythm’s planned case for Medicare reimbursement, but remain modelled estimates rather than evidence from real-world use.
Ada Torres
Ada Torres
7 Oct 2026
Vitasora says its remote-care model is now functioning, with estimated September-quarter revenue of US$1.028 million and a September exit rate of about US$17,400 a day. The next test is execution: turning planned Care Coordinator hiring into sustained, reconciled revenue and operational break-even.
Ada Torres
Ada Torres
6 Oct 2026
ReNerve’s October AGM presentation points to sharply higher sales, a growing US distribution network and a broader nerve repair pipeline. The company is also progressing a 240-patient NervAlign clinical study while relying on a $5 million RiverFort funding facility to support expansion.
Victor Sage
Victor Sage
5 Oct 2026
HealthCo Healthcare and Wellness REIT has signed binding agreements for new leases covering its remaining 10 Healthscope hospitals, subject to final approvals. The resolution allows HCW to reinstate quarterly distributions while reducing its largest tenant concentration from 57% to 31%.
Eva Park
Eva Park
5 Oct 2026
Stakk has executed a five-year US$9 million agreement with US banking technology provider Candescent, with its AI-powered cheque and document intelligence already deployed. The contract commits approximately US$1.8 million in annual revenue through 2030 and is expected to contribute above Stakk’s FY2027 revenue milestone.
Sophie Babbage
Sophie Babbage
2 Oct 2026
Promisia Healthcare has completed its acquisition of Chatswood Retirement Village after receiving shareholder approval in August. The vendors were paid through the issue of 1 million ordinary shares and 1 million unquoted convertible notes, leaving key transaction terms to be assessed in future disclosures.
Victor Sage
Victor Sage
1 Oct 2026
Vection Technologies delivered its first positive full-year operating cash flow and a sharp rise in adjusted EBITDA in FY26. Yet the audited report warns that continued operations depend on stronger sales, margin gains, cost reductions and potential access to further capital.
Sophie Babbage
Sophie Babbage
30 Sept 2026
Iperion reported a lower loss for the year ended 31 March 2026, but its cash reserves and net assets fell sharply, leaving the NZX-listed materials company reliant on related-party funding and director support. Its Pathoglaze manufacturing operation is also being moved from Malaysia to Singapore while customer trials continue.
Victor Sage
Victor Sage
30 Sept 2026
Alcidion will roll out its Miya Flow software across four Northern Care Alliance hospitals under a new A$7.5 million contract. About A$4.5 million is expected to be recognised as revenue in the current year, including a six-month renewal of the existing ExtraMed system during implementation.
Victor Sage
Victor Sage
30 Sept 2026
RAM Essential Services Property Fund has posted a $30.1 million FY2026 statutory loss as property values weakened, while its planned $218.6 million retail sale prepares the fund for a healthcare-focused reset. The transaction could reduce gearing to 16.8%, but FY2027 distribution guidance is below the latest payout and refinancing remains unfinished.
Eva Park
Eva Park
29 Sept 2026
TrivarX has made Stabl-Im its central development bet, but the ASX-listed health technology company also reported an $8.76 million FY2026 loss and an auditor-flagged material uncertainty over its ability to continue without further funding. The planned Phase 1 study remains subject to regulatory, ethics and operational clearances.
Ada Torres
Ada Torres
29 Sept 2026

Browse the archive

Full archive